Daiana Ibarretxe

Low HDL and high triglycerides predict COVID-19 severity

L. Masana, Eudald Correig, Daiana Ibarretxe et al. · Scientific Reports · 2021 · 197 citations · Full text

Veterinary Medicine, Clinical Sciences, Infectious Diseases +12

HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk

Josefa Girona, Núria Amigó, Daiana Ibarretxe et al. · International Journal of Molecular Sciences · 2019 · 106 citations · Full text

Medicine, Clinical Sciences, Diabetology +16

The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario

Josefa Girona, Cèlia Rodríguez-Borjabad, Daiana Ibarretxe et al. · Journal of Clinical Medicine · 2019 · 68 citations · Full text

Life Sciences, Biochemistry, Physiology +16

Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia

Tawfeg Ben‐Omran, L. Masana, Genovefa Kolovou et al. · Advances in Therapy · 2019 · 53 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Long-term exposure to PM10 above WHO guidelines exacerbates COVID-19 severity and mortality

Montse Marquès, Eudald Correig, Daiana Ibarretxe et al. · Environment International · 2021 · 47 citations · Full text

Public Health, Health Sciences, Infectious Diseases +17